期刊文献+

依达拉奉对脑梗死患者血清中sICAM-1和sE-selectin的影响 被引量:2

下载PDF
导出
摘要 目的:探讨依达拉奉对脑梗塞患者血清可溶性细胞间粘附分子(sICAM-1)和可溶性E-选择素(sE-selectin)的影响。方法:72例脑梗死患者随机分为常规组(常规治疗)35例和依达拉奉组(依达拉奉+常规治疗,生理盐水100m l加入依达拉奉30mg,1d 2次,连续14d,iogtt)37例,检测治疗前和治疗后14d患者血清中可溶性细胞间粘附分子和可溶性E-选择素(sE-selectin)浓度的变化及2组的疗效。结果:依达拉奉组疗效显著优于常规组(P<0.01),且依达拉奉组治疗后患者血清sICAM-1和sE-selectin的浓度较常规组明显下降,两者比较有显著性差异(P<0.01、P<0.05)。结论:早期对脑梗塞患者进行依达拉奉治疗可以减轻缺血脑细胞的损害、有利于病情的康复,其对脑缺血神经元的保护机制可能与抑制ICAM-1和E-selectin的产生,从而阻断了白细胞向缺血区的浸润有关。
出处 《河南大学学报(医学版)》 CAS 2006年第2期33-34,共2页 Journal of Henan University:Medical Science
  • 相关文献

参考文献7

  • 1Hallenberk J M, Datka A G, Tanishia T,et al. Polymorphonuclear leukocyte accumulation in brain regions with low blood during the postischemic [ J ]. Stroke, 1985,17 : 246 - 253.
  • 2Garcia J H,Liu K F,Yoshida Y, et al. Influx of leukocytes and plateles in an evolving brain infarct( wistar rat) [J]. Am J pathol,1994,144 - 199.
  • 3Davies M J, Gordon J L, Hcaring A L, et al. The expression of the adhesion molecules ICAM - 1, VCAM - 1 and E - selectin in human atheroscerosis [ J ]. J Pathal, 1993 , 17 ( 1 ) : 223.
  • 4杨杰,杨期东.脑梗死患者血清中TNF-α、sICAM-1的变化及其临床意义[J].脑与神经疾病杂志,2002,10(1):39-41. 被引量:6
  • 5Lo SK , Lees, Romes R A, et al. Endothelial - leukocyte adhesion molecule - 1 stimulate the adhesive activity of leukocyte integrin CR3 ( CD11 b/CD3 ), - mac - 1 am - 13 on human neutrophils [ J ]. JEX Med, 1991,173 : 1493 - 1500.
  • 6Nishi H , Watanabe T, Sakurai H, et al. Effect of MCI - 186 on brain edema in rats [J]. Strake,1989 ,20 :1236 - 1240.
  • 7杨政,吴玉林.治疗急性脑梗死的新型脑保护药依达拉奉[J].中国新药杂志,2002,11(12):911-913. 被引量:352

二级参考文献13

  • 1横田慎一 熊毅雄治 内海光朝.A Pharmacokinetic Study of MCI—186,a novel drug for cerebrovascular disease in elderly and young healthy subjects[J].临床药理,1997,28(3):693-702.
  • 2Mizuno A,Umemura K,Nakashima M.Inhibitory effect MCI-186,a free radical scavenger,on cerebral ischemia following rat middle cerebral artery occlusion[J].Gen Pharmacol,1998,30(4)∶575-578.
  • 3Kawai H,Nakai H,Misao S,et al.Effects of a novel free radical scavenger,MCI-186,on ischemic brain damage in the rat distal middle cerebral artery occlusion model[J].J Pharmacol Exp Ther,1997,281(2)∶921-927.
  • 4Tabrizchi R.Edaravone Mitsubishi-Tokyo[J].Curr Opin Investig Drugs,2000,1(3)∶347-454.
  • 5Yamamoto T,Yuki S,Watanabe T,et al.Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia[J].Brain Res,1997,762(12)∶240-242.
  • 6Watanabe T,Egawa M.Effects of an antistroke agent MCI-186 on cerebral arachidonate cascades[J].J Pharmacol Exp Ther,1994,271(3)∶1624-1629.
  • 7Watanabe T,Morita I,Nishi H,et al.Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro[J].Prostaglandins Leukotrienes Essent Fatty Acids,1998,33(1)∶81-87.
  • 8Mitsumori K,Sakuragi M,Kitami K,et al.The effect MCI-186 on regional cerebral blood flow in patients with acute cerebral infarction-A sequential SPECT study[J].Ther Res,1998,19(4)∶1333-1345.
  • 9山本美奈子 高松康雄.Pharmacokinetic studies of 3—methyl—1—phenyl—2—pyrazolin—5—one(MCI—186):protein binding and distribution to red blood cell[J].药理と治疗,1997,25(17):1755-1763.
  • 10大友英一 东仪英夫 小暮久也.MCI—186の脑梗死急性期に对する效果[J].Ther Res,1998,19(4):1311-1332.

共引文献356

同被引文献14

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部